NDC 69097-642
emtricitabine
Emtricitabine
emtricitabine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Emtricitabine.
| Product ID | 69097-642_51787789-f222-42a1-b86b-8ca898722879 |
| NDC | 69097-642 |
| Product Type | Human Prescription Drug |
| Proprietary Name | emtricitabine |
| Generic Name | Emtricitabine |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-08-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA091168 |
| Labeler Name | Cipla USA Inc. |
| Substance Name | EMTRICITABINE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |